Schrodinger Inc
SDGR19.943USD
+0.413+2.11%
Horário de mercado （ET）Cotações atrasadas em 15 min
1.46BValor de mercado
PerdaP/L TTM
Mais detalhes de Schrodinger Inc Empresa
Schrodinger, Inc. operates a physics-based computational platform that enables the discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The Company operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The Company's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.
Informações da empresa
Código da empresaSDGR
Nome da EmpresaSchrodinger Inc
Data de listagemFeb 06, 2020
CEODr. Ramy Farid, Ph.D.
Número de funcionários891
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 06
Endereço1540 Broadway
CidadeNEW YORK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal10036
Telefone15032991150
Sitehttps://www.schrodinger.com
Código da empresaSDGR
Data de listagemFeb 06, 2020
CEODr. Ramy Farid, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
Michael M. Lynton ,
Michael M. Lynton ,
Independent Chairman of the Board
Independent Chairman of the Board
12.25K
+95.95%
Ms. Bridget Anne Van Kralingen
Ms. Bridget Anne Van Kralingen
Independent Director
Independent Director
11.50K
+14.99%
Mannix Aklian
Mannix Aklian
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing
--
--
Mr. Gary Ginsberg, J.D.
Mr. Gary Ginsberg, J.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Richard A. Friesner, Ph.D.
Dr. Richard A. Friesner, Ph.D.
Director
Director
1.24M
+0.49%
Mr. Kenneth Patrick (Patrick) Lorton
Mr. Kenneth Patrick (Patrick) Lorton
Executive Vice President, Chief Operating Officer - Software
Executive Vice President, Chief Operating Officer - Software
36.99K
-30.96%
Ms. Margaret Dugan, M.D.
Ms. Margaret Dugan, M.D.
Chief Medical Officer
Chief Medical Officer
25.97K
+92.81%
Ms. Yvonne Tran, J.D.
Ms. Yvonne Tran, J.D.
Chief People Officer, Executive Vice President, Chief Legal Officer
Chief People Officer, Executive Vice President, Chief Legal Officer
23.64K
+112.26%
Mr. Arun Oberoi
Mr. Arun Oberoi
Independent Director
Independent Director
12.25K
+95.95%
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Dr. Rosana Kapeller-Libermann, M.D., Ph.D.
Independent Director
Independent Director
12.25K
+95.95%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
Other
2.38M
4.00%
Por RegiãoUSD
Nome
Receita
Proporção
United States
29.66M
49.81%
EMEA
23.08M
38.76%
APAC
6.07M
10.20%
Rest of World
731.00K
1.23%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
On-premise software
25.42M
42.69%
Hosted software
10.87M
18.26%
Drug discovery services
10.24M
17.19%
Software maintenance
6.80M
11.41%
Contribution
3.84M
6.45%
Other
2.38M
4.00%
Distribuição de ações
Atualizado em: sex, 23 de mai
Atualizado em: sex, 23 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.07%
Bill & Melinda Gates Foundation Trust
10.87%
The Vanguard Group, Inc.
10.17%
Rubric Capital Management LP
7.48%
Nikko Asset Management Co., Ltd.
5.68%
Other
53.73%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
12.07%
Bill & Melinda Gates Foundation Trust
10.87%
The Vanguard Group, Inc.
10.17%
Rubric Capital Management LP
7.48%
Nikko Asset Management Co., Ltd.
5.68%
Other
53.73%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.38%
Investment Advisor/Hedge Fund
25.00%
Hedge Fund
13.63%
Endowment Fund
10.87%
Individual Investor
2.65%
Research Firm
2.22%
Pension Fund
0.80%
Bank and Trust
0.49%
Venture Capital
0.13%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
570
67.20M
104.65%
-5.08M
2025Q1
593
67.21M
104.69%
-5.43M
2024Q4
576
64.44M
100.89%
-9.04M
2024Q3
581
67.44M
105.91%
-6.15M
2024Q2
573
64.76M
101.80%
-8.12M
2024Q1
574
63.48M
100.05%
-5.40M
2023Q4
584
62.06M
98.56%
-7.64M
2023Q3
586
63.62M
101.35%
-15.42M
2023Q2
584
64.04M
102.20%
-7.30M
2023Q1
543
57.09M
91.59%
-11.19M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
7.75M
12.07%
-354.21K
-4.37%
Mar 31, 2025
Bill & Melinda Gates Foundation Trust
6.98M
10.87%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
6.53M
10.17%
-72.09K
-1.09%
Mar 31, 2025
Rubric Capital Management LP
4.80M
7.48%
-200.00K
-4.00%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
3.46M
5.39%
-48.10K
-1.37%
Mar 31, 2025
UBS Asset Management (Switzerland)
2.47M
3.85%
+919.38K
+59.31%
Mar 31, 2025
Stephens Investment Management Group, LLC
1.97M
3.07%
+362.29K
+22.53%
Mar 31, 2025
State Street Global Advisors (US)
2.21M
3.44%
-104.66K
-4.52%
Mar 31, 2025
MFS Investment Management
2.09M
3.26%
-186.23K
-8.17%
Mar 31, 2025
ARK Investment Management LLC
2.29M
3.57%
+85.76K
+3.88%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
ARK Genomic Revolution ETF
3.78%
TrueShares Technology, AI & Deep Learning ETF
2.24%
Global X HealthTech ETF
1.25%
SPDR FactSet Innovative Technology ETF
0.97%
WisdomTree BioRevolution Fund
0.84%
Franklin Exponential Data ETF
0.81%
Invesco S&P SmallCap Health Care ETF
0.8%
Franklin Genomic Advancements ETF
0.63%
First Trust Multi-Manager Small Cap Opportunities ETF
0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.44%
Ver Mais
ARK Genomic Revolution ETF
Proporção3.78%
TrueShares Technology, AI & Deep Learning ETF
Proporção2.24%
Global X HealthTech ETF
Proporção1.25%
SPDR FactSet Innovative Technology ETF
Proporção0.97%
WisdomTree BioRevolution Fund
Proporção0.84%
Franklin Exponential Data ETF
Proporção0.81%
Invesco S&P SmallCap Health Care ETF
Proporção0.8%
Franklin Genomic Advancements ETF
Proporção0.63%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporção0.46%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.44%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
